Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARATANA THERAPEUTICS, INC. | 5,184,942 | reported | 19 May 2017 | tx 2+729,500−7,295 |
| Corium International, Inc. | 4,068,626 | reported | 02 Nov 2017 | tx 2−368,100 |
| AVADEL PHARMACEUTICALS PLC | 3,130,573 | reported | 31 Jan 2019 | tx 3+27,900−261,000 |
| Recro Pharma, Inc. | 2,520,262 | reported | 13 Dec 2017 | tx 17+1,040,000−365,445 |
| QLT INC/BC | 9,600 | reported | 22 Dec 2016 | tx 2+9,600−9,600 |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 0 | reported | 11 Feb 2022 | tx 10+6,722,222−4,001,156 |
| Aegerion Pharmaceuticals, Inc. | 0 | reported | 29 Nov 2016 | tx 2+75,000−4,361,291 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2022 | CONVERSION | BIODELIVERY SCIENCES INTERNATIONAL INC | 2,422,222 | 1.80 USD | |
| 11 Feb 2022 | CONVERSION | BIODELIVERY SCIENCES INTERNATIONAL INC | 436 | 10000.00 USD | deriv |
| 11 May 2021 | PURCHASE | BIODELIVERY SCIENCES INTERNATIONAL INC | 150,000 | 3.16 USD | first after silence |
| 13 May 2021 | PURCHASE | BIODELIVERY SCIENCES INTERNATIONAL INC | 50,000 | 3.25 USD | |
| 12 May 2021 | PURCHASE | BIODELIVERY SCIENCES INTERNATIONAL INC | 100,000 | 3.24 USD | |
| 18 Nov 2019 | SALE | BIODELIVERY SCIENCES INTERNATIONAL INC | 293,757 | 5.90 USD | |
| 18 Nov 2019 | SALE | BIODELIVERY SCIENCES INTERNATIONAL INC | 1,500,000 | 5.90 USD | |
| 15 Nov 2019 | SALE | BIODELIVERY SCIENCES INTERNATIONAL INC | 2,206,243 | 6.04 USD | |
| 18 Nov 2019 | CONVERSION | BIODELIVERY SCIENCES INTERNATIONAL INC | 4,000,000 | 1.80 USD | |
| 18 Nov 2019 | CONVERSION | BIODELIVERY SCIENCES INTERNATIONAL INC | 720 | 10000.00 USD | deriv |
| 31 Jan 2019 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 27,900 | 0.00 USD | |
| 12 Dec 2017 | SALE | Recro Pharma, Inc. | 100 | 9.89 USD | |
| 13 Dec 2017 | SALE | Recro Pharma, Inc. | 9,900 | 9.84 USD | |
| 12 Dec 2017 | SALE | Recro Pharma, Inc. | 50,000 | 9.80 USD | |
| 12 Dec 2017 | SALE | Recro Pharma, Inc. | 25,000 | 10.00 USD | |
| 13 Dec 2017 | SALE | Recro Pharma, Inc. | 8,237 | 9.80 USD | |
| 05 Dec 2017 | SALE | Recro Pharma, Inc. | 100,000 | 10.00 USD | |
| 21 Nov 2017 | SALE | Recro Pharma, Inc. | 2,440 | 9.37 USD | |
| 24 Nov 2017 | SALE | Recro Pharma, Inc. | 1,450 | 9.48 USD | |
| 24 Nov 2017 | SALE | Recro Pharma, Inc. | 5,900 | 9.37 USD | |
| 21 Nov 2017 | SALE | Recro Pharma, Inc. | 100,000 | 9.50 USD | |
| 22 Nov 2017 | SALE | Recro Pharma, Inc. | 48,566 | 9.37 USD | |
| 22 Nov 2017 | SALE | Recro Pharma, Inc. | 3,088 | 9.36 USD | |
| 24 Nov 2017 | SALE | Recro Pharma, Inc. | 2,913 | 9.32 USD | |
| 24 Nov 2017 | SALE | Recro Pharma, Inc. | 2,051 | 9.31 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 May 2021.